Search results for "Angioneurotic oedema"

showing 2 items of 2 documents

The care pathway for children with urticaria, angioedema, mastocytosis

2015

Cutaneous involvement characterized by urticarial lesions with or without angioedema and itch is commonly observed in routine medical practice. The clinical approach may still remain complex in real life, because several diseases may display similar cutaneous manifestations. Urticaria is a common disease, characterized by the sudden appearance of wheals, with/without angioedema. The term Chronic Urticaria (CU) encompasses a group of conditions with different underlying causes and different mechanisms, but sharing the clinical picture of recurring wheals and/or angioedema for at least 6 weeks. Hereditary Angioedema (HAE) is a rare disorder characterized by recurrent episodes of non-pruritic,…

lcsh:Immunologic diseases. AllergyPulmonary and Respiratory MedicineAllergyUrticariaEpidemiologyImmunologyReviewClinical practiceAngioedema; Children; Clinical practice; Diagnosis; Epidemiology; Itch; Management; Mastocytosis; Skin; UrticariaItchC1-inhibitor030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineimmune system diseasesEdemaDiagnosismedicineImmunology and AllergyAngioedemaskin and connective tissue diseasesChildrenSkinbiologyAngioedemabusiness.industryAutosomal dominant traitAngioneurotic oedemamedicine.diseasePathophysiologyManagement3. Good healthUrticaria Angioedema Mastocytosis Skin Itch Children Epidemiology Diagnosis Management Clinical practice.030228 respiratory systemImmunologyHereditary angioedemabiology.proteinmedicine.symptomlcsh:RC581-607businessMastocytosisWorld Allergy Organization Journal
researchProduct

Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs

2002

Background Adverse reactions to non-steroidal anti-inflammatory drugs (NSAID)s are frequent, and the need to identify a safe alternative drug is a common problem in clinical practice. Objective To assess the tolerability of rofecoxib, a drug that specifically inhibits COX-2, in a group of NSAID-sensitive patients. Methods One-hundred and four subjects (29 males and 75 females, mean age 35.6 ± 14.1) were enrolled. All subjects had experienced one or more episode characterized by cutaneous symptoms (erythema, and/or urticaria angioedema) following the assumption of NSAIDs; 92 subjects experienced reactions to only one NSAID (single intolerance: SI) and 12 subjects had reactions to multiple NS…

medicine.medical_specialtyAspirinAngioedemaErythemabusiness.industryImmunologyAngioneurotic oedemaPlacebolaw.inventionTolerabilityRandomized controlled triallawInternal medicineAnesthesiamedicineImmunology and Allergymedicine.symptomskin and connective tissue diseasesbusinessRofecoxibmedicine.drugClinical & Experimental Allergy
researchProduct